ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA)
CUSIP: 488445206
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 56,066,823
- Total 13F shares
- 39,900,415
- Share change
- +3,632,592
- Total reported value
- $379,438,207
- Put/Call ratio
- 55%
- Price per share
- $9.51
- Number of holders
- 164
- Value change
- +$36,779,127
- Number of buys
- 106
- Number of sells
- 47
Quarterly Holders Quick Answers
What is CUSIP 488445206?
CUSIP 488445206 identifies ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 488445206:
Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Woodline Partners LP |
13F
13D/G
|
Company |
6.2%
from 13D/G
|
4,615,676
|
$40,664,106 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
7.4%
|
4,168,000
|
$36,720,080 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.6%
from 13D/G
|
4,081,544
|
$35,958,402 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.3%
|
2,952,686
|
$26,013,163 | — | 30 Jun 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
4%
|
2,225,000
|
$21,159,750 | -$13,551,750 | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
4.1%
|
2,289,243
|
$20,168,227 | — | 30 Jun 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
3.5%
|
1,958,318
|
$17,252,782 | — | 30 Jun 2025 | |
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
4.4%
|
2,340,333
|
$16,920,608 | -$4,220,064 | 31 Dec 2024 | |
| Samuel J. Braun |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,153,000
|
$15,636,043 | — | 13 May 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
1,242,386
|
$10,947,721 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
1,241,658
|
$10,939,007 | — | 30 Jun 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
2%
|
1,125,000
|
$9,911,250 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
1.7%
|
935,677
|
$8,243,315 | — | 30 Jun 2025 | |
| AIGH Capital Management LLC |
13F
|
Company |
1.6%
|
918,893
|
$8,095,448 | — | 30 Jun 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
1.4%
|
775,620
|
$6,833,212 | — | 30 Jun 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
1.3%
|
715,000
|
$6,299,150 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
634,820
|
$5,592,764 | — | 30 Jun 2025 | |
| Retirement Planning Co of New England, Inc. |
13F
|
Company |
0.99%
|
553,297
|
$4,874,547 | — | 30 Jun 2025 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.8%
|
450,000
|
$3,964,500 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.76%
|
425,119
|
$3,745,298 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.67%
|
374,792
|
$3,301,918 | — | 30 Jun 2025 | |
| Mystic Asset Management, Inc. |
13F
|
Company |
0.62%
|
346,652
|
$3,054,004 | — | 30 Jun 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.56%
|
315,469
|
$2,779,282 | — | 30 Jun 2025 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.46%
|
256,664
|
$2,261,000 | — | 30 Jun 2025 | |
| Propel Bio Management, LLC |
13F
|
Company |
0.41%
|
231,874
|
$2,042,810 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.4%
|
223,852
|
$1,972,135 | — | 30 Jun 2025 | |
| Stratos Wealth Partners, LTD. |
13F
|
Company |
0.39%
|
220,000
|
$1,938,200 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.38%
|
213,088
|
$1,877,313 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.34%
|
189,313
|
$1,667,847 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.29%
|
161,967
|
$1,426,929 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.29%
|
161,493
|
$1,422,753 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
154,184
|
$1,358,361 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.27%
|
148,904
|
$1,311,844 | — | 30 Jun 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.26%
|
147,000
|
$1,295,070 | — | 30 Jun 2025 | |
| Kovack Advisors, Inc. |
13F
|
Company |
0.26%
|
146,788
|
$1,293,200 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.26%
|
146,284
|
$1,288,761 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.26%
|
143,132
|
$1,260,993 | — | 30 Jun 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.22%
|
121,225
|
$1,067,992 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
118,975
|
$1,048,172 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.21%
|
118,233
|
$1,042,000 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.2%
|
114,267
|
$1,006,692 | — | 30 Jun 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.2%
|
111,515
|
$982,447 | — | 30 Jun 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
0.19%
|
108,000
|
$951,480 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.19%
|
104,351
|
$919,332 | — | 30 Jun 2025 | |
| Travis C. Mickle |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
171,774
|
$851,845 | — | 25 May 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.16%
|
88,414
|
$778,923 | — | 30 Jun 2025 | |
| Campbell & CO Investment Adviser LLC |
13F
|
Company |
0.15%
|
83,245
|
$733,388 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.15%
|
83,221
|
$733,165 | — | 30 Jun 2025 | |
| Arete Wealth Advisors, LLC |
13F
|
Company |
0.13%
|
74,789
|
$659,000 | — | 30 Jun 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.13%
|
70,300
|
$619,343 | — | 30 Jun 2025 |
Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) as of Q3 2025
As of 30 Sep 2025,
ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,900,415 shares.
The largest 10 holders included
BlackRock, Inc., Woodline Partners LP, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Nantahala Capital Management, LLC, FMR LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, AIGH Capital Management LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
164
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
119
Q3 2025 holders
164
Holder diff
45
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.